Source: Beamtree
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Beamtree (BMT) signs a key strategic partnership with Lean following the successful completion of the company’s first major contract in Saudi Arabia
  • This new partnership will support the proposed implementation of PICQ and related data products in Saudi Arabia if selected by health authorities or hospitals
  • According to the company, the partnership with Lean is expected to support Beamtree’s goal of achieving annual recurring revenue of $60 million by 2026
  • Shares in Beamtree end the day 10.9 per cent in the red to close at 25.5 cents

Beamtree (BMT) has signed a key strategic partnership with Lean following the successful completion of the company’s first major contract in Saudi Arabia.

Lean is the country’s leading provider of innovative health solutions and contributes to digitalising the health ecosystem in Saudi Arabia.

Overall, the partnership aims to support health services, improve the quality of hospital data and analytic insight through the audit and automation of clinical record classification.

This new partnership will support the proposed implementation of PICQ and related data products in Saudi Arabia if selected by health authorities or hospitals.

PICQ is the company’s SaaS-based product which automates the audit of classification and supports clinical record coders to improve the quality of data. It is widely used in countries including Australia, New Zealand and Ireland.

This follows after the successful completion of phase one of an audit of public hospitals which the company had received full payment of US$1.45 million (A$2 million).

Beamtree CEO Tim Kelsey said the company is delighted to launch the new partnership.

“[We] believe it will leverage both Lean and Beamtree’s existing products and services to support improved health outcomes in Saudi Arabia,” he said.

According to the company, the partnership with Lean is expected to support Beamtree’s goal of achieving annual recurring revenue of $60 million by 2026.

Shares in Beamtree ended the day 10.9 per cent in the red to close at 25.5 cents.

BMT by the numbers
More From The Market Online
Molecules

Proteomics scores Aussie patent for oxidative stress blood test ‘attracting wide-range interest’

Proteomics International Laboratories Ltd has secured a patent in Australia for its OxiDx test to assess…
Bunyoni lake in Uganda

eMetals kicks off early exploration work at Ugandan gold project

eMetals Ltd has begun a soil sampling program at the Busia Gold Project in Uganda, where…
FDA Approval

Artrya pops +11% on yet another FDA approval for an Aussie biotech

Artrya (ASX:AYA) is the latest Aussie biotech stock to see an FDA approval and consequent rewarding…
Arizona landscape

Helix branches out with White Hills copper-gold project in Arizona

Helix Resources Ltd is planning to add to its portfolio of copper and gold projects in…